Petvivo Holdings, INC 8-K filings

PetVivo Holdings, Inc. will be delisted from the Nasdaq Stock Market, effective ten days after September 6, 2024, and will continue trading on the OTCQB Venture Market.

PetVivo Holdings will transition its stock and warrants to the OTCQB Venture Market after the Nasdaq Board of Directors declined to review the delisting decision.

PetVivo Holdings raised $1.21 million through a private offering of preferred stock and warrants, while facing potential delisting from the Nasdaq stock market.

PetVivo Holdings announced its fiscal year 2024 results, highlighting a 6% increase in revenue driven by expanded distribution of its Spryng veterinary medical device.

PetVivo Holdings raised approximately $1.1 million through a private offering of units and the conversion of a convertible note into equity.

PetVivo Holdings converted a $301,558 promissory note held by A.L. Sarroff Fund into 430,798 units, each consisting of one share of common stock and one warrant.

PetVivo Holdings implements salary reductions for senior executives, including the Chief Operating Officer, as part of a company-wide cost reduction program.

PetVivo Holdings, Inc. has initiated a company-wide cost reduction program, including significant salary reductions for its CEO and Chief Business Development Officer, effective May 1, 2024.

PetVivo Holdings granted its CEO, John Lai, 150,000 restricted stock units (RSUs) on April 15, 2024, fully vesting immediately.

PetVivo Holdings has entered into a promissory note with a major shareholder for $300,000, which may be converted into shares and warrants.

PetVivo Holdings will have its stock and warrants suspended from trading on the Nasdaq due to not meeting the minimum stockholders' equity requirement, with trading expected to move to the OTC market.

PetVivo Holdings, Inc. has appointed Garry Lowenthal as its new Chief Financial Officer, effective March 8, 2024.

PetVivo Holdings has terminated its at-the-market sales agreement with ThinkEquity, effective March 7, 2024, after raising $959,033 through the sale of 674,000 shares.

PetVivo Holdings, Inc. has dual listed its common stock on the Upstream exchange, a global securities trading app, to broaden access for international investors.

PetVivo Holdings, Inc. announced its third quarter fiscal 2024 financial results, highlighting increased revenue and a reduced net loss compared to the same period last year.

PetVivo Holdings converted a $120,000 promissory note, plus accrued interest, into 164,340 shares of common stock at a conversion price of $0.75 per share.

PetVivo Holdings has completed a private offering, issuing warrants and restricted stock to accredited investors, raising approximately $1.25 million.

PetVivo Holdings has announced the membership of its Audit, Compensation, and Nominating and Corporate Governance Committees following the Annual Meeting of Stockholders held on November 17, 2023.

PetVivo Holdings' Chief Financial Officer, Robert J. Folkes, has resigned effective February 2, 2024, but will continue to provide services during the transition period.